The United States spends approximately 17% of GDP on healthcare — nearly double the average of other high-income countries — yet achieves inferior outcomes on key health metrics including life expectancy, maternal mortality, and chronic disease prevalence. The comparison between U.S. fee-for-service and managed care models and the universal coverage systems of Germany, France, the United Kingdom, Canada, Japan, and South Korea offers lessons for healthcare reform and commercial opportunity identification. The global healthcare systems comparison also identifies the international market opportunities for U.S. healthcare companies — insurance, distribution, technology, and services — in markets with growing healthcare investment.
Topics Covered
• Healthcare Spending Comparison by Country
• Universal Coverage Models
• U.S. Healthcare System Performance
• European Healthcare Systems
• Asian Healthcare Systems
• Healthcare Reform Initiatives
• International Expansion Opportunities for U.S. Companies
Table of Contents
1. Executive Summary
2. Market and Policy Overview
3. Healthcare Spending Comparison by Country
4. Universal Coverage Models
5. U.S. Healthcare System Performance
6. European Healthcare Systems
7. Asian Healthcare Systems
8. Healthcare Reform Initiatives
9. International Expansion Opportunities for U.S. Companies
10. Strategic Conclusions and Recommendations
11. Appendix
List of Tables
Table 1. Policy and Market Overview 2025
Table 2. Healthcare Spending Comparison by Country
Table 3. Universal Coverage Models
Table 4. U.S. Healthcare System Performance
Table 5. European Healthcare Systems
Table 6. Asian Healthcare Systems
Table 7. Healthcare Reform Initiatives
Table 8. International Expansion Opportunities for U.S. Companies
Table 9. Leading Companies — Strategy and Response 2025
Table 10. Regulatory Timeline and Key Dates
Table 11. Key Risks and Mitigation Strategies
Companies Profiled
Aetna
Anthem
Centene
Cigna
CVS Health
Elevance Health
Humana
Molina Healthcare
UnitedHealth Group
